<DOC>
	<DOCNO>NCT02043886</DOCNO>
	<brief_summary>Postprandial hypotension carry risk significant morbidity morbidity include syncope , fall , dizziness , fatigue , stroke myocardial infarction . Current therapy consist dietary manipulation ( small meal ) caffeine octreotide injection suboptimal poorly study . The study hypothesis administration Acarbose decrease drop blood pressure increase heart rate response food people Type 2 diabetes . Acarbose suppress postprandial glycemia slow digestion small intestine delay gastric emptying . This placebo-controlled cross study involve 2 - 4 hour Meal Tests . During meal test heart rate , blood pressure , cerebral artery velocity measure . During one meal test subject receive Acarbose 50 mg po receive placebo . Order treatment assignment do randomized fashion . A total approximately 200 cc blood drawn meal test .</brief_summary>
	<brief_title>Acarbose , Postprandial Hypotension Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<criteria>age 65 year old Type 2 diabetes less 65 year age</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Type 2 Diabetes , Postprandial Hypotension , Acarbose</keyword>
</DOC>